GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cipher Pharmaceuticals Inc (OTCPK:CPHRF) » Definitions » Other Operating Expense

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Other Operating Expense : $1.23 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Cipher Pharmaceuticals Other Operating Expense?

Cipher Pharmaceuticals's Other Operating Expense for the three months ended in Dec. 2023 was $0.27 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was $1.23 Mil.

Cipher Pharmaceuticals's quarterly Other Operating Expense declined from Jun. 2023 ($0.34 Mil) to Sep. 2023 ($0.27 Mil) but then increased from Sep. 2023 ($0.27 Mil) to Dec. 2023 ($0.27 Mil).

Cipher Pharmaceuticals's annual Other Operating Expense increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.99 Mil) and increased from Dec. 2022 ($0.99 Mil) to Dec. 2023 ($1.23 Mil).


Cipher Pharmaceuticals Other Operating Expense Historical Data

The historical data trend for Cipher Pharmaceuticals's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cipher Pharmaceuticals Other Operating Expense Chart

Cipher Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.99 1.23

Cipher Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.34 0.34 0.27 0.27

Cipher Pharmaceuticals Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cipher Pharmaceuticals Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Cipher Pharmaceuticals's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Cipher Pharmaceuticals (Cipher Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products among others. The company's geographical operational areas include Canada and the United States.

Cipher Pharmaceuticals (Cipher Pharmaceuticals) Headlines